Frazier Life Sciences X, L.P. - Apr 4, 2024 Form 4 Insider Report for HilleVax, Inc. (HLVX)

Role
10%+ Owner
Signature
FRAZIER LIFE SCIENCES X, L.P. By FHMLS X, L.P., its general partner By FHMLS X, L.L.C., its general partner By: /s/ Steve R. Bailey, Chief Financial Officer
Stock symbol
HLVX
Transactions as of
Apr 4, 2024
Transactions value $
$128,325
Form type
4
Date filed
4/8/2024, 04:22 PM
Previous filing
May 3, 2022
Next filing
Sep 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HLVX Common Stock Purchase $128K +8.85K +0.1% $14.50 8.54M Apr 4, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held directly by Frazier Life Sciences X, L.P. FHMLS X,, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. James N. Topper and Patrick J. Heron are the sole managing members of FHMLS X, L.L.C. and share voting and investment power over the shares held by Frazier Life Sciences X, L.P. Dr. Topper and Mr. Heron disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.